AC Ventures
Scbd Prosperity Tower Level 37 Unit B Office District 8 52-53 Scbd Lot 28, Jakarta, Jakarta Raya, 12190, Indonesia
Overview
Founded in 2014, AC Ventures is a Southeast Asian venture capital firm that invests in early-stage startups focused on Indonesia and ASEAN, with over US$500 million in assets under management across five funds. The firm’s areas of investment focus on a variety of industries, including digital enablement, financial technologies, agriculture technologies, logistics, e-commerce, consumer technology, MSME solutions, waste management, renewable energy, and sustainability solutions.
- Total investments
- 61
- Lead investments
- 17
- Investments · 12mo
- 3
- Active investors
- 8
Sector focus
- Financial Services
Investment portfolio
- Rovia
Participated · Seed · Jun 2026
Rovia provides a unified platform for employees with equity compensation to transfer, manage, diversify, and reinvest RSUs and other stock plans. The Bengaluru-based startup was co-founded in 2025 by Shivang Badaya and Arnav Grover and positions itself to reduce cross-border frictions, FX and remittance costs, tax complexities, and access barriers to US brokerage infrastructure. After launching a beta, Rovia reports 100% month-on-month growth in assets under management and is tracking over $60 million in equity compensation assets from employees at more than 300 companies. The company has secured registration as an SEC-registered investment adviser in the United States. Rovia plans to use its recent pre-seed funding to grow engineering and product teams, deepen brokerage and financial infrastructure integrations, and bolster regulatory and compliance capabilities as it scales.
- immunitoAI
Participated · Series A · Nov 2025
Founded in November 2020 by Aridni Shah and Trisha Chatterjee in Bengaluru, immunitoAI operates at the intersection of biotechnology and AI. Its core product is a generative AI platform that creates entirely new antibody sequences for any target antigen, shrinking discovery timelines from four–five years to roughly 11–12 months. The company maintains an in-house wet lab to validate and test the computer-generated antibodies. immunitoAI plans to earn revenue through three channels: selling proprietary antibody IP, undertaking custom antibody development projects for pharmaceutical clients, and eventually offering end-to-end drug development as a fully integrated pharma company. The startup is currently pre-revenue, but management projects that a single custom-developed antibody could fetch about USD 300 million plus royalties. By reducing discovery costs and timelines by more than 50%, the platform aims to accelerate targeted therapies for diseases such as cancer and autoimmune disorders. The newly raised capital will fund the development of trial-ready antibodies for specific diseases, advancing the company toward commercialization.
- Welkinrim
Participated · Equity · Sep 2025
Welkinrim is a deep-tech startup incubated at the IIT Madras Incubation Cell that builds advanced propulsion subsystems—specifically high-thrust-density motors and intelligent electronic speed controllers (ESCs)—for drone OEMs in defence, surveillance, agriculture, and logistics. Its products aim to deliver higher performance, reliability, and efficiency, addressing a critical gap in India’s UAV supply chain while targeting global demand. With the freshly raised ₹4.76 crore, the company plans to expand in-house manufacturing, invest in advanced testing infrastructure, and accelerate product validation with leading drone makers. Funds will also bolster R&D, grow the core engineering team, and help build intellectual property around proprietary control algorithms. By moving from prototyping to scaled deployments, Welkinrim seeks to become the preferred OEM partner for drone propulsion solutions. No revenue or user metrics were disclosed, but the company positions itself as a key enabler of the rapidly expanding drone ecosystem.
- Phot.AI
Participated · Seed · Mar 2025
Phot.AI leverages AI agents to automate design creation and generate product images, ads, and social media content tailored to specific platforms. The platform provides AI-powered tools for image manipulation, text-to-art generation, editing, and enhancement. Founded in 2023 by Venus Dhuria, Aneesh Rayancha, and Akshit Raja and based in Gurugram, the company recently raised $2.7M in a seed round. Phot.AI will use the funds to expand the team, invest in R&D, and launch an AI-powered copilot to enhance e-commerce creative automation. The seed round underscores the company’s focus on scaling product development and go-to-market efforts. The round included participation from a mix of VCs and angels, signaling broad investor interest in its category.
- TakeMe2Space
Participated · Seed · Mar 2025
TakeMe2Space is a Hyderabad-headquartered space-tech startup that is turning satellites into shared, programmable compute infrastructure for researchers and enterprises. Its flagship product, OrbitLab, allows users to upload and execute AI models on-orbit, paying only for the processing time they consume. The company launched its first major satellite, MOI-1, in 2026 and is now working toward a constellation of six networked spacecraft that will deliver roughly 5 kW of in-orbit compute capacity and inter-satellite communications. Proceeds from the current financing will fund R&D for next-generation computer satellites, expand partnerships with ground-station and AIT providers, and scale its presence across India, the United States, and Australia. Management also plans to grow the team from 17 to about 60 employees across engineering and global sales. By transforming satellites into orbital data centers, TakeMe2Space aims to offer customers near real-time edge computing in space, dramatically lowering the barrier to orbital experimentation and deployment. No revenue or user figures were disclosed in the article.